We hypothesized that alteration of these metabolic pathways in the TCblR/CD320 KO mouse, will produce Cbl deficiency and yield abnormal behavioral performance. This evidence concerns the gene CD320 and hyperinsulinemic hypoglycemia, familial, 4.